Therapeutics
Developing drugs that target novel biological pathways
Bioprocessing
Products to enhance manufacturing efficiency and economics
Repligen welcomes Novozymes Biopharma’s Cell Growth Factors to our family of manufacturing products--click here for an overview.
Highlights
- Dec 21, 2011: Repligen Announces Submission of New Drug Application for SecreFlo™ for Improved Pancreatic Imaging In Patients with Pancreatitis More
- Dec 20, 2011: Repligen Completes Acquisition of Novozymes Biopharma Sweden AB More
- Oct 27, 2011: Repligen Acquires Business of Novozymes Biopharma Sweden AB More